E. W. Alton

Biomarkers for cystic fibrosis lung disease: application of SELDI-TOF mass spectrometry to BAL fluid.

A. Bush, G. MacGregor, M. Imrie, 2008, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

Preparation for a first-in-man lentivirus trial in patients with cystic fibrosis

A. Doherty, T. Maher, A. Rodriguez-Martinez, 2016, Thorax.

Assessment of F/HN-pseudotyped lentivirus as a clinically relevant vector for lung gene therapy.

M. Hasegawa, S. Hyde, R. Farley, 2012, American journal of respiratory and critical care medicine.

Toxicology study assessing efficacy and safety of repeated administration of lipid/DNA complexes to mouse lung

D. Porteous, R. Scheule, J. Davies, 2013, Gene Therapy.

A mild variant of cystic fibrosis.

E. Alton, E. W. Alton, 1996, Thorax.

A randomised, double-blind, placebo-controlled phase IIB clinical trial of repeated application of gene therapy in patients with cystic fibrosis

D. Porteous, G. Murray, Seng H. Cheng, 2013, Thorax.

The safety profile of a cationic lipid-mediated cystic fibrosis gene transfer agent following repeated monthly aerosol administration to sheep.

R. Scheule, J. Davies, S. Hyde, 2013, Biomaterials.

Optimizing aerosol gene delivery and expression in the ovine lung.

D. Porteous, R. Scheule, Seng H. Cheng, 2007, Molecular therapy : the journal of the American Society of Gene Therapy.

Poster Session Abstracts

Simon J. S. Cameron, E. W. Alton, A. Bush, 2016, Pediatric pulmonology.